Associate Editor, Pharmaceutical Executive Europe
This year's Ad Stars embrace creativity through the eyes of the patients. Ben Comer and Jennifer Ringler report.
Jim Currie and Baber Ghauri talk to Pharm Exec about making connections that resonate with audiences in a digital world.
Making real connections that resonate with audiences in a digital world is a fine art, especially in the heavily regulated world of Big Pharma
After two years of waiting, FDA issued the first in a series of planned guidelines on social media at the end of last year. We look at some of the experts' reactions.
Pharma must coordinate the efforts of medical, legal, HR, global partners and many other players in the regulatory compliance space to keep itself afloat in choppy seas.
Over 25 years the Rx Club Show has reflected dramatic technological changes in advertising. But, as always, the subject comes first, the medium second. So where did the accolades go this year?
Abbey Meyers, Founder, National Organization of Rare Disorders
The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal.
A Q&A with Andrew Webber, President and CEO of the National Business Coalition on Health
Supply Chain Strategy: Managing risk and opportunity in a changing global landscape
Sponsored By PricewaterhouseCoopers LLP Optimizing the Multi-Sponsor REMS Experience (Risk Evaluation & Mitigation Strategies)
Sponsored By PricewaterhouseCoopers LLP Effective Resource Planning: Reducing Clinical Project Risk and Operating Cost
Sponsored By ClearTrial